VeriMomtussilago farfara leaf extract est-il sûr pendant la grossesse ?
Tussilago farfara extracts are known to contain hepatotoxic and genotoxic pyrrolizidine alkaloids; animal studies show tumorigenicity and case reports link PA‑containing herbal use in pregnancy to infant liver damage, supporting a suspected reproductive/ developmental hazard (h=2). Evidence indicates a demonstrated toxic mechanism for PAs (genotoxic/hepatotoxic) rather than a purely theoretical structural alert (m=2). For topical cosmetic use, systemic exposure is expected to be low but measurable if PAs are present in the extract (e=1). (ECHA substance entry; PubMed carcinogenicity study; EFSA/PA reviews).
Alternatives sûres à tussilago farfara leaf extract pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- tussilago farfara leaf extract est-il sûr pendant la grossesse ?
- Tussilago farfara extracts are known to contain hepatotoxic and genotoxic pyrrolizidine alkaloids; animal studies show tumorigenicity and case reports link PA‑containing herbal use in pregnancy to infant liver damage, supporting a suspected reproductive/ developmental hazard (h=2). Evidence indicates a demonstrated toxic mechanism for PAs (genotoxic/hepatotoxic) rather than a purely theoretical structural alert (m=2). For topical cosmetic use, systemic exposure is expected to be low but measurable if PAs are present in the extract (e=1). (ECHA substance entry; PubMed carcinogenicity study; EFSA/PA reviews).
- tussilago farfara leaf extract est-il sûr pendant l'allaitement ?
- Same hazard drivers apply during lactation—PAs are hepatotoxic/genotoxic and have been implicated in neonatal/infant liver injury after maternal herbal use. Mechanistic data for PA toxicity apply (m=2). Topical use would generally give low but potentially measurable systemic exposure (e=1), so transfer in milk is plausible if maternal systemic levels occur. (ECHA; EFSA PA opinion; case reports and toxicology literature).
- tussilago farfara leaf extract est-il sûr pour la peau de bébé ?
- No infant‑specific studies found, so hazard and mechanism remain those from PA toxicity (h=2, m=2). Because infant skin has higher absorption (immature barrier, higher surface‑area:weight) and PAs are small molecule toxins that can be systemically available, exposure score is increased by +1 relative to adult topical use (adult e=1 → baby e=2). No data justify raising hazard or mechanism beyond adult scores. (EFSA/PA reviews; toxicology literature).
- Comment VeriMom évalue-t-il tussilago farfara leaf extract ?
- VeriMom évalue tussilago farfara leaf extract à 40/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tussilago farfara leaf extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tussilago farfara leaf extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.